53 results
20-F/A
2023 FY
BLRX
BioLineRx Ltd.
26 Mar 24
Annual report (foreign) (amended)
4:57pm
Compensation Committee and board of directors should be able to judge the suitability of a bonus payment by deliberating retrospectively at year end … and comparing actual performance and target achievements against the forecasted operating plan. The annual bonus mechanism will be directly tied to meeting
6-K
EX-99
BLRX
BioLineRx Ltd.
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
restatement, the Company shall be entitled to recover from Office Holders bonus compensation granted, earned or vested based on the Company’s pre-accounting … bonus compensation granted, earned or vested based on the Company’s pre-accounting restatement financial results in the amount of the excess over what
6-K
EX-1
5ligxnfepszfxua
28 May 19
Current report (foreign)
7:04am
6-K
EX-10.4
u2yppwvy4vkfyb
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
20-F/A
t8dt3da0 8z
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
1l607u727y uy
6 Mar 15
Prospectus supplement for primary offering
12:00am